Global Intravenous (IV) Solution Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 156649
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 119
  • list Pharmaceuticals and Healthcare

Intravenous (IV) Solution are intended to be administered to the patients which are deficient in nutrients or at the time of serious dehydration. These solutions are given to the patients whose fluid volume or body nutrients falls.

Scope of the Report:

This report focuses on the Intravenous (IV) Solution in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Many companies manufactures packaged intravenous fluids or products or compounds which can be mixed with sterile water to prepare a solution for intravenous administration. The market for intravenous solutions is growing swiftly.

The worldwide market for Intravenous (IV) Solution is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

ICU Medical

B. Braun Melsungen

Fresenius Kabi

Baxter

Amanta Healthcare

Terumo Medical Corporation

Grifols

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Total Parenteral Solution

Peripheral Parenteral Solution

Market Segment by Applications, can be divided into

Hospitals & Clinics

Ambulatory

Homecare

There are 15 Chapters to deeply display the global Intravenous (IV) Solution market.

Chapter 1, to describe Intravenous (IV) Solution Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Intravenous (IV) Solution, with sales, revenue, and price of Intravenous (IV) Solution, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Intravenous (IV) Solution, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Intravenous (IV) Solution market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Intravenous (IV) Solution sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Intravenous (IV) Solution Introduction

1.2 Market Analysis by Type

1.2.1 Total Parenteral Solution

1.2.2 Peripheral Parenteral Solution

1.3 Market Analysis by Applications

1.3.1 Hospitals & Clinics

1.3.2 Ambulatory

1.3.3 Homecare

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 ICU Medical

2.1.1 Business Overview

2.1.2 Intravenous (IV) Solution Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 ICU Medical Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 B. Braun Melsungen

2.2.1 Business Overview

2.2.2 Intravenous (IV) Solution Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 B. Braun Melsungen Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Fresenius Kabi

2.3.1 Business Overview

2.3.2 Intravenous (IV) Solution Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Fresenius Kabi Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Baxter

2.4.1 Business Overview

2.4.2 Intravenous (IV) Solution Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Baxter Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Amanta Healthcare

2.5.1 Business Overview

2.5.2 Intravenous (IV) Solution Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Amanta Healthcare Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Terumo Medical Corporation

2.6.1 Business Overview

2.6.2 Intravenous (IV) Solution Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Terumo Medical Corporation Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Grifols

2.7.1 Business Overview

2.7.2 Intravenous (IV) Solution Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Grifols Intravenous (IV) Solution Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Intravenous (IV) Solution Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Intravenous (IV) Solution Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Intravenous (IV) Solution Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Intravenous (IV) Solution Manufacturer Market Share in 2017

3.3.2 Top 6 Intravenous (IV) Solution Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Intravenous (IV) Solution Market Analysis by Regions

4.1 Global Intravenous (IV) Solution Sales, Revenue and Market Share by Regions

4.1.1 Global Intravenous (IV) Solution Sales and Market Share by Regions (2013-2018)

4.1.2 Global Intravenous (IV) Solution Revenue and Market Share by Regions (2013-2018)

4.2 North America Intravenous (IV) Solution Sales and Growth Rate (2013-2018)

4.3 Europe Intravenous (IV) Solution Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Intravenous (IV) Solution Sales and Growth Rate (2013-2018)

4.5 South America Intravenous (IV) Solution Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Intravenous (IV) Solution Sales and Growth Rate (2013-2018)

5 North America Intravenous (IV) Solution by Countries

5.1 North America Intravenous (IV) Solution Sales, Revenue and Market Share by Countries

5.1.1 North America Intravenous (IV) Solution Sales and Market Share by Countries (2013-2018)

5.1.2 North America Intravenous (IV) Solution Revenue and Market Share by Countries (2013-2018)

5.2 United States Intravenous (IV) Solution Sales and Growth Rate (2013-2018)

5.3 Canada Intravenous (IV) Solution Sales and Growth Rate (2013-2018)

5.4 Mexico Intravenous (IV) Solution Sales and Growth Rate (2013-2018)

6 Europe Intravenous (IV) Solution by Countries

6.1 Europe Intravenous (IV) Solution Sales, Revenue and Market Share by Countries

6.1.1 Europe Intravenous (IV) Solution Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Intravenous (IV) Solution Revenue and Market Share by Countries (2013-2018)

6.2 Germany Intravenous (IV) Solution Sales and Growth Rate (2013-2018)

6.3 UK Intravenous (IV) Solution Sales and Growth Rate (2013-2018)

6.4 France Intravenous (IV) Solution Sales and Growth Rate (2013-2018)

6.5 Russia Intravenous (IV) Solution Sales and Growth Rate (2013-2018)

6.6 Italy Intravenous (IV) Solution Sales and Growth Rate (2013-2018)

7 Asia-Pacific Intravenous (IV) Solution by Countries

7.1 Asia-Pacific Intravenous (IV) Solution Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Intravenous (IV) Solution Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Intravenous (IV) Solution Revenue and Market Share by Countries (2013-2018)

7.2 China Intravenous (IV) Solution Sales and Growth Rate (2013-2018)

7.3 Japan Intravenous (IV) Solution Sales and Growth Rate (2013-2018)

7.4 Korea Intravenous (IV) Solution Sales and Growth Rate (2013-2018)

7.5 India Intravenous (IV) Solution Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Intravenous (IV) Solution Sales and Growth Rate (2013-2018)

8 South America Intravenous (IV) Solution by Countries

8.1 South America Intravenous (IV) Solution Sales, Revenue and Market Share by Countries

8.1.1 South America Intravenous (IV) Solution Sales and Market Share by Countries (2013-2018)

8.1.2 South America Intravenous (IV) Solution Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Intravenous (IV) Solution Sales and Growth Rate (2013-2018)

8.3 Argentina Intravenous (IV) Solution Sales and Growth Rate (2013-2018)

8.4 Colombia Intravenous (IV) Solution Sales and Growth Rate (2013-2018)

9 Middle East and Africa Intravenous (IV) Solution by Countries

9.1 Middle East and Africa Intravenous (IV) Solution Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Intravenous (IV) Solution Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Intravenous (IV) Solution Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Intravenous (IV) Solution Sales and Growth Rate (2013-2018)

9.3 UAE Intravenous (IV) Solution Sales and Growth Rate (2013-2018)

9.4 Egypt Intravenous (IV) Solution Sales and Growth Rate (2013-2018)

9.5 Nigeria Intravenous (IV) Solution Sales and Growth Rate (2013-2018)

9.6 South Africa Intravenous (IV) Solution Sales and Growth Rate (2013-2018)

10 Global Intravenous (IV) Solution Market Segment by Type

10.1 Global Intravenous (IV) Solution Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Intravenous (IV) Solution Sales and Market Share by Type (2013-2018)

10.1.2 Global Intravenous (IV) Solution Revenue and Market Share by Type (2013-2018)

10.2 Total Parenteral Solution Sales Growth and Price

10.2.1 Global Total Parenteral Solution Sales Growth (2013-2018)

10.2.2 Global Total Parenteral Solution Price (2013-2018)

10.3 Peripheral Parenteral Solution Sales Growth and Price

10.3.1 Global Peripheral Parenteral Solution Sales Growth (2013-2018)

10.3.2 Global Peripheral Parenteral Solution Price (2013-2018)

11 Global Intravenous (IV) Solution Market Segment by Application

11.1 Global Intravenous (IV) Solution Sales Market Share by Application (2013-2018)

11.2 Hospitals & Clinics Sales Growth (2013-2018)

11.3 Ambulatory Sales Growth (2013-2018)

11.4 Homecare Sales Growth (2013-2018)

12 Intravenous (IV) Solution Market Forecast (2018-2023)

12.1 Global Intravenous (IV) Solution Sales, Revenue and Growth Rate (2018-2023)

12.2 Intravenous (IV) Solution Market Forecast by Regions (2018-2023)

12.2.1 North America Intravenous (IV) Solution Market Forecast (2018-2023)

12.2.2 Europe Intravenous (IV) Solution Market Forecast (2018-2023)

12.2.3 Asia-Pacific Intravenous (IV) Solution Market Forecast (2018-2023)

12.2.4 South America Intravenous (IV) Solution Market Forecast (2018-2023)

12.2.5 Middle East and Africa Intravenous (IV) Solution Market Forecast (2018-2023)

12.3 Intravenous (IV) Solution Market Forecast by Type (2018-2023)

12.3.1 Global Intravenous (IV) Solution Sales Forecast by Type (2018-2023)

12.3.2 Global Intravenous (IV) Solution Market Share Forecast by Type (2018-2023)

12.4 Intravenous (IV) Solution Market Forecast by Application (2018-2023)

12.4.1 Global Intravenous (IV) Solution Sales Forecast by Application (2018-2023)

12.4.2 Global Intravenous (IV) Solution Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Intravenous (IV) Solution Picture

Table Product Specifications of Intravenous (IV) Solution

Figure Global Sales Market Share of Intravenous (IV) Solution by Types in

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery